[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Talquetamab Side Effect Management

Talquetamab Side Effect Management image

Talquetamab Side Effect Management

Relapsed/Refractory Myeloma
event Sep 17, 2024 / 04:00PM - 05:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

While dealing with side effects related to your myeloma treatment can be tricky, information is power. Join us as Dr. Cesar Rodriguez discusses talquetamab side effect management. Wether it is a treatment you are currently receiving or one you may receive in the future, knowing what side effects you may experience and how to deal with them could make your treatment more comfortable.

Schedule & Agenda

The panelist Cynthia Cahoon
Introductions
4:00 PM
Cynthia Cahoon

Cynthia introduces the agenda of the event and featured speaker Dr. Cesar Rodriguez

The panelist Cesar Rodriguez, MD
Presentation
4:05 PM
Cesar Rodriguez, MD

Dr. Rodriguez discusses talquetamab side effect management

person
Questions and Answers
4:35 PM
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Cynthia Cahoon
Cynthia Cahoon

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Read Bio
The panelist Cesar Rodriguez, MD
Cesar Rodriguez, MD

Dr. Cesar Rodriguez is Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, and the Center of Excellence for Multiple Myeloma, and serves as Clinical Director of Multiple Myeloma at The Mount Sinai Hospital. Dr. Rodriguez has extensive experience treating patients with plasma cell disorders. He is a member of the International Myeloma Working Group which conducts collaborative research and produces consensus guidelines for the myeloma community. Dr. Rodriguez has more than 10 years of experience in clinical research and is the principal investigator of numerous clinical trials for multiple myeloma focused on early drug development and immunotherapies that include T cell and NK cell directed therapies. He is also working on a 3D organoid model to better understand the biology of the tumor niche.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your Myelodysplastic Syndromes delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Myelodysplastic Syndromes Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Genentech
Regeneron
Adaptive

Follow Us

facebook instagram youtube